SanBio Co(SNBIF)
$5.02-0.03 (-0.50%)
SNBIF
SanBio Co financials statements
$5.02
At close:-0.03 (-0.50%)
SanBio Co (SNBIF) Ratios
13 Followers
SanBio Co Ratios
SNBIF's free cash flow for Q3 2026 was ¥0.00. For the 2026 fiscal year, SNBIF's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 26 | Jan 25 | Jan 24 | Jan 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.56 | 28.99 | 5.45 | 6.39 | 3.66 |
| Quick Ratio | 4.56 | 28.99 | 5.45 | 6.39 | 3.34 |
| Cash Ratio | 3.99 | 28.23 | 4.92 | 6.18 | 3.11 |
| Solvency Ratio | -1.71 | -1.90 | -1.17 | -2.12 | -1.31 |
| Operating Cash Flow Ratio | -4.94 | -7.12 | -5.28 | -6.82 | -4.47 |
| Short-Term Operating Cash Flow Coverage | -13.50 | -29.50 | -17.83 | -27.74 | -12.77 |
| Net Current Asset Value | ¥ 1.65B | ¥ 13.47B | ¥ 2.68B | ¥ 4.35B | ¥ 1.88B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.08 | 0.13 | 0.13 | 0.46 |
| Debt-to-Equity Ratio | 0.23 | 0.09 | 0.24 | 0.21 | 1.24 |
| Debt-to-Capital Ratio | 0.18 | 0.08 | 0.19 | 0.17 | 0.55 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.08 | 0.12 | 0.13 | 0.50 |
| Financial Leverage Ratio | 1.96 | 1.15 | 1.81 | 1.59 | 2.71 |
| Debt Service Coverage Ratio | -9.95 | -17.87 | -15.75 | -18.68 | -8.06 |
| Interest Coverage Ratio | -185.64 | -46.81 | -175.84 | -312.60 | -148.43 |
| Debt to Market Cap | 0.01 | 0.01 | 0.02 | 0.02 | 0.05 |
| Interest Debt Per Share | 6.04 | 18.05 | 10.58 | 16.55 | 49.62 |
| Net Debt to EBITDA | 0.85 | 3.29 | 0.84 | 1.26 | 0.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 95.76% | 89.53% | 104.01% | 118.35% | 102.58% |
| EBT Per EBIT | 85.63% | 113.10% | 56.00% | 59.47% | 68.88% |
| Return on Assets (ROA) | -83.63% | -24.60% | -52.38% | -78.91% | -84.88% |
| Return on Equity (ROE) | -163.53% | -28.24% | -94.69% | -125.53% | -229.85% |
| Return on Capital Employed (ROCE) | -129.49% | -25.15% | -109.59% | -132.65% | -163.57% |
| Return on Invested Capital (ROIC) | -112.86% | -22.33% | -102.93% | -126.94% | -145.19% |
| Return on Tangible Assets | -84.70% | -24.67% | -52.84% | -78.93% | -85.92% |
| Earnings Yield | -5.81% | -2.84% | -7.15% | -12.90% | -8.34% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5418.78 | 0.00 | 0.00 | 0.00 | 1289.10 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 1289.10 |
| Days of Payables Outstanding | 5418.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 1289.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -52.52 | -52.05 | -73.15 | -128.36 | -126.41 |
| Free Cash Flow Per Share | -52.59 | -52.50 | -73.80 | -128.49 | -127.49 |
| Dividend Paid and CapEx Coverage Ratio | -739.46 | -116.02 | -86.93 | -928.92 | -116.74 |
| Capital Expenditure Coverage Ratio | -739.46 | -116.02 | -86.93 | -928.92 | -116.74 |
| Operating Cash Flow Coverage Ratio | -9.11 | -3.07 | -7.19 | -7.97 | -2.59 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -7.30% | -2.84% | -13.04% | -17.27% | -11.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.20 | -35.19 | -13.98 | -7.75 | -11.99 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 28.13 | 9.94 | 13.24 | 9.73 | 27.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.69 | -35.22 | -7.67 | -5.79 | -8.49 |
| Price-to-Operating Cash Flow Ratio | -13.71 | -35.53 | -7.74 | -5.80 | -8.57 |
| Price-to-Earnings Growth (PEG) Ratio | -5.05 | -1.38 | 0.24 | -1.24 | -0.31 |
| Enterprise Value Multiple | -15.78 | -28.87 | -7.33 | -8.08 | -12.36 |
| Enterprise Value | 47.06B | 121.35B | 33.18B | 37.29B | 54.06B |
| EV to EBITDA | -15.78 | -28.87 | -7.33 | -8.08 | -12.36 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -12.99 | -31.62 | -6.88 | -5.01 | -8.19 |
| EV to Operating Cash Flow | -13.01 | -31.89 | -6.94 | -5.02 | -8.26 |
| Tangible Book Value Per Share | 24.96 | 185.47 | 42.08 | 76.45 | 38.02 |
| Shareholders’ Equity Per Share | 25.60 | 186.07 | 42.75 | 76.47 | 39.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.10 | -0.04 | -0.18 | -0.03 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -41.86 | -52.55 | -40.48 | -95.99 | -90.33 |
| Tax Burden | 0.96 | 0.90 | 1.04 | 1.18 | 1.03 |
| Interest Burden | 1.01 | 1.02 | 0.56 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.25 | 0.99 | 1.88 | 1.58 | 1.44 |
Currency in JPY

